side effects of semaglutide and tirzepatide Weighing up the Risks: GI vs GLP-1 Side Effects Explained: What

While the difference was not dramatic (~3 points, which is well below the minimally clinically important difference in the MDS-UPDRS-3 of around ~5 points), it appeared to remain after a 2-month washout period, intended to support the idea that, because the improvements remained after removal of the incretin, the difference should be a disease-modifying, rather than a symptomatic benefit

To make this combination even more powerful, I recommend the addition of Vitamin C

While we await UK regulatory review, we offer the two leading GLP-1 weight loss injections , both MHRA-approved and available now through our UK prescribing service

Glucagon-Like Peptide-1 (GLP-1) receptor agonists clinical guidance